← Evidence map

ReviewCNS drugs2022

Kalirin as a Novel Treatment Target for Cognitive Dysfunction in Schizophrenia.

Arne W Mould et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2022
2023
2024
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 34928485